A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC
Clinical trial NCT02346370 · TERMINATED
Trial details
- NCT number
- NCT02346370
- Sponsor
- Halozyme Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-10
- Primary completion
- 2016-08-09
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.